Here is the link for information regarding the re-permitting process.

CPE Monitor is a national, collaborative effort by NABP and the Accreditation Council for Pharmacy Education (ACPE) to provide an electronic system for pharmacists and pharmacy technicians to track their completed continuing pharmacy education (CPE) credits. It will also offer state boards of pharmacy the opportunity to electronically authenticate the CPE units completed by their licensees, rather than requiring pharmacists and technicians to submit their proof of completion statements upon request or for random audits.

This initiative will streamline processes for pharmacy practitioners to ensure they are maintaining professional competency requirements. CPE Monitor is expected to save pharmacists, pharmacy technicians, state boards of pharmacy, and CPE providers time and money.

Pharmacy Technician Registration Update

On-Line Florida Pharmacy Technician Registration will begin on October 1, 2009
Apply online OR re-apply now

Prior to January 1, 2010:
Effective January 1, 2010, any person who wishes to work as a pharmacy technician in the State of Florida must register with the Board of Pharmacy. To register with the Board of Pharmacy, an applicant must submit the following items:

1. Pharmacy Technician Registration Application; and
2. $105.00 Fee ($50.00 non-refundable application fee, $50.00 registration fee, $5.00 unlicensed application fee).

January 1, 2010 through December 31, 2010:
An applicant who has not met the education, work experience or certification requirements at the time of initial application may utilize January 1, 2010 through December 31, 2010 to complete one of the requirements.

1. Must complete a board-approved pharmacy technician training program; or
2. Must complete 1500 hours pharmacy technician work experience under the supervision of a licensed pharmacist; or
3. Must be certified by an agency accredited by the National Commission for Certifying Agencies. For example, Pharmacy Technician Certification Board (PTCB), or Institute for the Certification of Pharmacy Technicians (ICPT).

After January 1, 2011: Effective January 1, 2011, any person who wishes to work as a pharmacy technician in the State of Florida must register with the Board of Pharmacy. To register with the Board of Pharmacy, an applicant must submit the following items:

1. Pharmacy Technician Registration Application
2. $105.00 Fee ($50.00 non-refundable application fee, $50.00 registration fee, $5.00 unlicensed application fee)
3. Proof of completion of a board-approved pharmacy technician-training program.

64B16-27.500 Negative Drug Formulary.
The negative drug formulary is composed of medicinal drugs which have been specifically determined by the Board of Pharmacy and the Board of Medicine to demonstrate clinically significant biological or therapeutic inequivalence and which, if substituted, could produce adverse clinical effects, or could otherwise pose a threat to the health and safety of patients receiving such prescription medications. Except where certain dosage forms are included on the negative drug formulary as a class, all medicinal drugs are listed by their official United States Pharmacopoeia Non-Proprietary (generic) name. The generic name of a drug shall be applicable to and include all brand-name equivalents of such drug for which a prescriber may write a prescription. Substitution by a dispensing pharmacist on a prescription written for any brand name equivalent of a generic named drug product listed on the negative formulary or for a drug within the class of certain dosage forms as listed, is strictly prohibited. In cases where the prescription is written for a drug listed on the negative drug formulary but a brand name equivalent is not specified by the prescriber, the drug dispensed must be one obtained from a manufacturer or distributor holding an approved new drug application or abbreviated new drug application issued by the Food and Drug Administration, United States Department of Health and Welfare permitting that manufacturer or distributor to market those medicinal drugs or when the former is non-applicable, those manufacturers or distributors supplying such medicinal drugs must show compliance with other applicable Federal Food and Drug Administration marketing requirements. The following are included on the negative drug formulary:

1. Digitoxin.
2. Conjugated Estrogen.
3. Dicumarol.
4. Chlorpromazine (Solid Oral Dosage Forms).
5. Theophylline (Controlled Release).
6. Levothyroxine Sodium.
7. Pancrelipase (Oral Dosage Forms).

From March 18, 2010 forward, a pharmacist that receives a prescription for a brand name drug shall, unless requested otherwise by the purchaser, substitute a less expensive, generically equivalent drug product that is listed in the formulary of generic and brand name drug products as provided in Section 465.025(5), F.S., unless:

The prescriber writes the words “MEDICALLY NECESSARY,” in her or his own handwriting, on the face of a written prescription; In the case of an oral prescription, the prescriber expressly indicates to the pharmacist that a brand name drug prescribed is medically necessary; or In the case of a prescription that is electronically generated and transmitted, the prescriber makes an overt act when transmitting the prescription to indicate that the brand name drug prescribed is medically necessary.

If you have any questions concerning this notice, you may contact the Board of Pharmacy by telephone at (850) 245-4292 or by email.